Mark Alles, former CEO of Celgene, testifies by video conference before the House Committee on Oversight and Reform on Wednesday (Pool via AP)
Dems slam drug pricing strategies as 18-month probe comes to an end
The House Oversight Committee held a pair of hearings this week on drug prices. And the Democrats on the panel did not hold back. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
